Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications

Documenti analoghi

• Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice
  di: Huijia Yang, et al.
  Pubblicazione: (2024)
• Amyloid‐β but not tau accumulation is strongly associated with longitudinal cognitive decline
  di: Wenwen Wang, et al.
  Pubblicazione: (2024)
• Histamine Modulation of the Basal Ganglia Circuitry in the Motor Symptoms of Parkinson's Disease
  di: Hui‐Xian Zhu, et al.
  Pubblicazione: (2025)
• Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology
  di: Sufang Liu, et al.
  Pubblicazione: (2025)
• Exploratory Analysis of the Association Between Plasma Ceramide Alterations and Cognitive Dysfunction in Parkinson's Disease
  di: Xu Liu, et al.
  Pubblicazione: (2024)